Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):783–792. doi: 10.1158/1055-9965.EPI-21-0398

Table 1. Summary of Findings.

Low grades were initially assigned to the included studies due to their observational nature. These initial grades were further downgraded for risk of bias due to inadequate control of confounding, short follow-up in some studies, and potential publication bias raised by detected small study effects. We upgraded the study when the observed effects were of considerable magnitude and showed a dose-response gradient.

The association between attained height and colorectal cancer or adenoma risk.
Patient population: colorectal cancer or adenoma
Settings: community and hospital
Risk factor: attained height
Outcomes Relative effect (95% CI) No. of studies Quality of the evidence (GRADE) Comments
HR of colorectal cancer per 10-cm increase in height HR 1.14 (1.11 to 1.17) 19 ⊕⊕⊝⊝
low
Downgraded for:
1. Inadequate control of confounding, short follow-up in some studies
2. Small study effect
Upgraded for:
1. Large magnitude of an effect
2. Dose-response gradient
OR of colorectal cancer per 10-cm increase in height RR 1.09 (1.05 to 1.13) 14 ⊕⊕⊕⊝
moderate
Downgraded for:
1. Inadequate control of confounding, short follow-up in some studies
Upgraded for:
1. Large magnitude of an effect
2. Dose-response gradient
HR of colorectal cancer comparing highest vs. lowest height percentile HR 1.24 (1.19 to 1.30) 19 ⊕⊕⊕⊝
moderate
Downgraded for:
1. Inadequate control of confounding, short follow-up in some studies
Upgraded for:
1. Large magnitude of an effect
2. Dose-response gradient
OR of colorectal cancer comparing highest vs. lowest height percentile OR 1.07 (0.92 to 1.25) 7 ⊕⊝⊝⊝
very low
Downgraded for:
1. Inadequate control of confounding, short follow-up in some studies;
2. Inconsistency of results across studies
3. Imprecision of overall estimate
Upgraded for:
1. Dose-response gradient
OR of colorectal adenoma per 10-cm increase in height OR 1.06 (1.00 to 1.12) 4 ⊕⊕⊝⊝
low
Downgraded for:
1. Inadequate control of confounding, short follow-up in some studies
Upgraded for:
1. Dose-response gradient